Jeuveau, or “Newtox,” is an injectable neurotoxin similar in structure to BOTOX®. As the first new injectable treatment to hit the market in a decade, Jeuveau is manufactured by Evolus and approved by the FDA to smooth away frown lines and create a refreshed, more youthful look.
HOW IS JEUVEAU DIFFERENT THAN BOTOX®?
Like BOTOX®, Jeuveau is used to temporarily paralyze the underlying facial muscles in the face, creating a smoother look and alleviating frown lines, and results last approximately three months. Jeuveau offers several advantages, and is quickly becoming the most requested alternative to BOTOX® because:
- Smooths lines and wrinkles like BOTOX®, at less cost.
- May be more effective if BOTOX® is no longer achieving results.
- May act more quickly than BOTOX®, and lasts longer for some people
As with BOTOX®, Jeuveau requires upkeep in order for the results to last long-term. The decreased price of this particular injectable treatment may therefore make Jeuveau more accessible to many people who want to retain a more youthful look, or ward off the development of lines and wrinkles.